Record free cash flow of approximately $700 million and achieved net cash position Increased 2025 share buyback target by 20% to $600 million and ...

NeoGenomics’ third quarter results were met with a negative market reaction, as shares declined following the announcement. Management attributed the quarter’s performance to robust growth in clinical ...

The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the third quarter 2025 following ...

“These results are encouraging, highlighting TET2-mutated clonal hematopoiesis as a potential biomarker to select patients ...

Twist Bioscience is advancing synthetic DNA manufacturing with innovation but remains at the lower end of its 52-week range.

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) reported Q3 CY2025 results , with sales up 11.9% year on year ...

NeoGenomics Inc. ( ($NEO) ) has released its Q3 earnings. Here is a breakdown of the information NeoGenomics Inc. presented to its investors.

Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...

Blair County is asking for a federal lawsuit filed by a former inmate who was attacked while in the prison's custody to be dismissed.

Abstract: This article pioneers in-situ monitoring of stress evolution in operational advanced packaging structures through embedded silicon-based piezoresistive sensors. During four-point bending ...

If you're wondering what generation of AirPods we're on, it varies by model. We are on the fourth generation of the standard AirPods, the second generation of the AirPods Pro, and the first generation ...